§ BIOTECHNOLOGY
USD · Biotechnology

IMNM

IMMUNOME INC
USDSector · BiotechnologyBeta · 2.52
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
114 increased/new, 62 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B3.74EPS (TTM)-2.36
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Fidelity Management17.0M0.0%+3%
BlackRock, Inc.8.2M0.0%+8%
Redmile Group, LLC5.6M8.1%−3%
State Street5.4M0.0%+40%
PRIMECAP MANAGEMENT CO/CA/4.8M0.1%+2%
WELLINGTON MANAGEMENT GROUP LLP4.7M0.0%+406%
◇ AC INTELLIGENCE

Top institutional owners for IMNM as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER95.6% · 0 holders
OTHER2.4% · 135 holders
QUALITY / COMPOUNDER0.9% · 14 holders
DEALER / BANK0.5% · 20 holders
PASSIVE / INDEX0.4% · 9 holders
INCOME / DEFENSIVE0.1% · 13 holders
SYSTEMATIC / QUANT0.1% · 8 holders
TACTICAL / MACRO0.0% · 3 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for IMNM in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention IMNM yet.